| vol3 N°42 | Is Sudden Death a Threat in Aortic Stenosis? | Rosenhek R. MD
| 05 Jul 2005 |
| Vol3 N°41 | More effective but not more expensive : the Add-on therapy of Metoprolol Succinate leads to a better treatment in patients with Chronic Heart Failure (CHF) in Germany. | Sonntag F. FESC, Hass B, Schoeffski O. MPH
| 28 Jun 2005 |
| Vol3 N°39 | Microvascular damage assessment using MRI in reperfused acute myocardial infarction | Lombardi M. FESC
| 22 Jun 2005 |
| Vol3 N°40 | Potential applications of magnetic navigation in clinical electrophysiology | Jordaens L. FESC, Rivero-Ayerza M, Thornton A
| 20 Jun 2005 |
| Vol3 N°38 | Prolonged ECG monitoring in patients with syncope | Brignole M. FESC
| 08 Jun 2005 |
| Vol3 N°36 | Erythropoietin therapy to treat Anaemia in Chronic Heart Failure | Coats AJS, MA, DM, DSc, FRACP, FRCP, FESC, FACC, FAHA, MBA
| 01 Jun 2005 |
| Vol3 N°37 | Hypersensitivity to aspirin in patients with coronary artery disease : rapid desensitisation is feasible | Steg PH.G FESC
| 31 May 2005 |
| Vol3 N°35 | Mechanical Complications of Acute Myocardial Infarction (AMI) | Ghanim D. and Hasin Y. FESC
| 17 May 2005 |
| Vol3 N°34 | Short QT Syndrome : A new primary electrical disease | Borggrefe M. FESC, Wolpert C, Veltmann C, Giustetto C, Gaita F, Schimpf R.
| 10 May 2005 |
| Vol3 N°33 | Management of hypertension in patients with peripheral artery disease. | Clement DL. FESC, MD, PhD
| 26 Apr 2005 |
| Vol3 N°32 | Imaging the perfusion/function match with Gated SPECT | Paolo Marzullo, MD, FACC, FESC. Nucleus Member and past Chairman Working Group Nuclear Cardiology. Director, Nuclear Cardiology, CNR Pisa, Italy.
| 19 Apr 2005 |
| Vol3 N°30 | Medical Treatment of Acute Heart Failure: New Insights | Hodt A. and Atar D. FESC
| 12 Apr 2005 |
| Vol3 N°31 | Exercise can reduce the risk of cardiovascular disease in people with type 2 diabetes | Hu G. MD, MPH, PhD, Jousilahti P. MD, MSc, PhD, Tuomilehto J. MD, MPolSc, PhD, FESC
| 12 Apr 2005 |
| Vol3 N°29 | How to approach a patient with syncope | Dr M. Brignole M. FESC
| 29 Mar 2005 |
| Vol3 N°28 | Glycoprotein IIb-IIIa inhibitors during PCI: current indications | Di Mario C. FESC, Neumann J, Tanigawa J. and Goktekin O. FESC
| 22 Mar 2005 |
| Vol3 N°27 | Reducing Recurrent Ulcer Bleedings in Cardiology – The Role of Aspirin, Clopidogrel, and Proton-Pump Inhibitors | Böhm M.
| 15 Mar 2005 |
| Vol3 N°26 | Genetics and Atrial Fibrillation | Brugada J. M.D, FESC
| 08 Mar 2005 |
| Vol3 N°25 | Aspirin Resistance – Clinically Meaningful or A Laboratory Artefact? | Blinc A.
| 01 Mar 2005 |
| Vol3 N°24 | Aldosterone, the Underrecognised Factor in Cardiovascular Damage | Duprez D. FESC
| 22 Feb 2005 |
| Vol3 N°23 | Additional features of beta-blockers | Stoschitzky K. FESC
| 14 Feb 2005 |
| Vol3 N°22 | Real-Time 3D Echocardiography in the Assessment of Mitral Valve Disease. | Perez de Isla L. FESC and Zamorano J. FESC
| 08 Feb 2005 |
| Vol3 N°21 | The immediate anti-thrombotic therapy in patients with acute coronary syndromes. | Huber K. FESC, De Caterina R. FESC and Kristensen SD. FESC
| 01 Feb 2005 |
| Vol3 N°20 | American and European Guidelines for Hypertension Management: Agreements and Disagreements | Grassi G.
| 25 Jan 2005 |
| Vol3 N°19 | Medical Therapy to Slow Aortic Stenosis Progression? | Rosenhek R.
| 18 Jan 2005 |
| Vol3 N°18 | Assessing of Preclinical & Clinical Atherosclerosis and Related Risk: Using the Ankle–Brachial Index | Poredos P. FESC
| 10 Jan 2005 |
| Vol3 N°17 | Imaging Cardiac Resynchronisation Therapy (CRT) | Marzullo P. FESC
| 04 Jan 2005 |
| Vol3 N°16 | Be careful before stopping aspirin ! | Steg Ph.G. FESC
| 21 Dec 2004 |
| Vol3 N°15 | New and Old Echocardiographic Parameters for the Assessment of Left Ventricular Function in Mitral Regurgitation | Agricola E. MD, Pisani M. MD, Oppizzi M. MD.
| 14 Dec 2004 |
| Vol3 N°06 | Secondary prevention of peripheral arterial disease | Poredos P. FESC
| 10 Dec 2004 |
| Vol3 N°14 | ST-elevation myocardial infarction – should choice of reperfusion therapy depend on the duration of symptoms? | Kristensen SD. FESC, Huber K. FESC and De Caterina R. FESC
| 06 Dec 2004 |
| Vol3 N°13 | Neurohormonal markers in the assessment of mitral regurgitation | Syed FF, Ray SG. FESC and Prendergast B.
| 30 Nov 2004 |
| Vol3 N°12 | Treatment of Refractory Angina Pectoris | Lanza GA. MD, FESC ; Crea F. MD, PhD, FESC, FACC
| 23 Nov 2004 |
| Vol3 N°11 | Hypertension and ethnicity – a perspective | Lip G.YH. MD, FESC
| 14 Nov 2004 |
| Vol3 N°10 | Cardiovascular Disease Prevention - Risk Assessment and Management | Nikol S.
| 10 Nov 2004 |
| Vol3 N°09 | Asymptomatic individuals with a Brugada electrocardiogram should undergo electrophysiological testing. | Brugada J. FESC
| 03 Nov 2004 |
| Vol3 N°08 | Cardiac resynchronisation therapy: what any clinician should know | Brignole M. FESC
| 26 Oct 2004 |
| Vol3 N°07 | Children from families with premature coronary heart disease. Biochemical risk markers beyond traditional risk factors. | Wojakowski W. FESC, Tendera M. FESC
| 19 Oct 2004 |
| Vol3 N°04 | Assessment of end-organ damage in hypertension: Rationale, Indications and Therapeutic Implications | Grassi G.
| 06 Oct 2004 |
| Vol3 N°05 | Increase HDL-Cholesterol, a new approach in cardiovascular risk reduction | Duprez D. MD, PhD, FACC, FAHA, FESC
| 05 Oct 2004 |
| Vol3 N°03 | Spironolactone, Hyperkalemia and Heart Failure | Werner N. and M. Böhm M.
| 29 Sep 2004 |
| Vol3 N°02 | Toll Like receptors and the atherosclerotic disease | De Kleign D. and Pasterkamp G. FESC
| 22 Sep 2004 |
| Vol3 N°01 | n-3 fatty acids in the secondary prevention of coronary heart disease | De Caterina R. FESC, Schmidt EB. FESC, Kristensen SD. FESC
| 15 Sep 2004 |